New Insights into Immunotherapy Induced Myocarditis
CD8 T cells specific for alpha-myosin are biomarkers in immunotherapy related myocarditis
Source: medindia.net
Page 19 - Ancer Immunotherapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ancer Immunotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ancer Immunotherapy Today - Breaking & Trending Today
Augmented drug preferentially eliminates cancer cells but does not harm healthy cells
Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of targeted approach a "prodrug" -; a medicine designed to release its payload in a particular area of the body and in no other areas.
Source: news-medical.net
Machine learning algorithm predicts a tumor's response to immune checkpoint blockade
Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades.
Source: news-medical.net
Akoya Biosciences launches PhenoCode Signature Panels
Each panel focuses on distinct areas of tumor biology and response to therapy
Source: selectscience.net
Sanofi hits reset on drug from $2.5B deal after 'lower than projected' efficacy in trials
Sanofi did not see the efficacy it wanted in mid-stage tests of a cytokine therapy from its $2.5 billion acquisition of Synthorx. While the pharmaceutical giant isn’t giving up on the drug, it said it will restart the molecule in a new Phase 1/2 program, a setback that will lead to a €1.6 billion financial writedown.
Source: medcitynews.com